Dr Reddy’s Laboratories has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (Montelukast Sodium) oral granules in the US market, following the approval by the United States Food & Drug Administration (USFDA) of its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Oral Granules.
The Singulair Oral Granules brand had US sales of about $61 million for the most recent twelve months ending July 2012 according to IMS Health. The company’s Montelukast Sodium Oral Granules in 4mg are available in unit dosage package of 30.
Recently, the company launched Amoxicillin tablets Capsules and Oral Suspension, a bioequivalent generic version of Amoxil tablets, capsules and Oral Suspension in the US markets on September 17, 2012.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1868.80 |
| Dr. Reddys Lab | 1283.85 |
| Cipla | 1304.45 |
| Zydus Lifesciences | 942.85 |
| Lupin | 2269.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: